BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 32519512)

  • 21. Role of white matter in cognitive impairment among relapsing remitting multiple sclerosis patients.
    Elkhooly M; Bao F; Raghib M; Millis S; Bernitsas E
    Mult Scler Relat Disord; 2023 Nov; 79():105030. PubMed ID: 37837669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
    Moroso A; Ruet A; Lamargue-Hamel D; Munsch F; Deloire M; Coupé P; Charré-Morin J; Saubusse A; Ouallet JC; Planche V; Tourdias T; Dousset V; Brochet B
    PLoS One; 2017; 12(8):e0182479. PubMed ID: 28792528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY; Vitorino RC; Hojjat SP; Mulholland AD; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
    Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
    Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis.
    Cassiano MT; Lanzillo R; Alfano B; Costabile T; Comerci M; Prinster A; Moccia M; Megna R; Morra VB; Quarantelli M; Brunetti A
    Neuroimage Clin; 2020; 26():102201. PubMed ID: 32062567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of morphological and microstructural integrity of the corpus callosum on cognition, fatigue and depression in mildly disabled MS patients.
    Van Schependom J; Gielen J; Laton J; Sotiropoulos G; Vanbinst AM; De Mey J; Smeets D; Nagels G
    Magn Reson Imaging; 2017 Jul; 40():109-114. PubMed ID: 28438714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
    Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
    Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White matter microstructural alterations in clinically isolated syndrome and multiple sclerosis.
    Huang J; Liu Y; Zhao T; Shu N; Duan Y; Ren Z; Sun Z; Liu Z; Chen H; Dong H; Li K
    J Clin Neurosci; 2018 Jul; 53():27-33. PubMed ID: 29754967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive functions in multiple sclerosis: impact of gray matter integrity.
    Llufriu S; Martinez-Heras E; Fortea J; Blanco Y; Berenguer J; Gabilondo I; Ibarretxe-Bilbao N; Falcon C; Sepulveda M; Sola-Valls N; Bargallo N; Graus F; Villoslada P; Saiz A
    Mult Scler; 2014 Apr; 20(4):424-32. PubMed ID: 24005025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
    Asaf A; Evan S; Anat A
    Neuroimage Clin; 2015; 8():261-6. PubMed ID: 26106550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking Microstructural Integrity and Motor Cortex Excitability in Multiple Sclerosis.
    Radetz A; Mladenova K; Ciolac D; Gonzalez-Escamilla G; Fleischer V; Ellwardt E; Krämer J; Bittner S; Meuth SG; Muthuraman M; Groppa S
    Front Immunol; 2021; 12():748357. PubMed ID: 34712236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
    Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
    Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis.
    Vinciguerra C; Giorgio A; Zhang J; Nardone V; Brocci RT; Pastò L; Niccolai C; Stromillo ML; Mortilla M; Amato MP; De Stefano N
    Brain Imaging Behav; 2021 Aug; 15(4):2228-2233. PubMed ID: 33033983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.
    Roostaei T; Sadaghiani S; Mashhadi R; Falahatian M; Mohamadi E; Javadian N; Nazeri A; Doosti R; Naser Moghadasi A; Owji M; Hashemi Taheri AP; Shakouri Rad A; Azimi A; Voineskos AN; Nazeri A; Sahraian MA
    Mult Scler; 2019 Apr; 25(4):532-540. PubMed ID: 29485352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
    Meijer KA; Muhlert N; Cercignani M; Sethi V; Ron MA; Thompson AJ; Miller DH; Chard D; Geurts JJ; Ciccarelli O
    Mult Scler; 2016 Oct; 22(11):1429-1437. PubMed ID: 26733423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis.
    Chylińska M; Karaszewski B; Komendziński J; Wyszomirski A; Hałas M; Szurowska E; Sabisz A
    Neurol Sci; 2023 Sep; 44(9):3221-3232. PubMed ID: 37103603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
    Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
    Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.